Allergan

Strong Botox sales boost Allergan profit
Reuters
Wed, 05/1/13 - 09:44 am
Allergan
Botox
earnings
FDA panel says Allergan's Juvederm data supports product effectiveness
Yahoo/Fly on the Wall
Tue, 04/30/13 - 08:53 am
FDA
Allergan
Juvederm
advisory panels
facial fillers
FDA declines to approve new Allergan migraine drug
Reuters
Tue, 04/16/13 - 12:06 pm
FDA
migraines
Levadex
Allergan
J&J's answer to Botox may escalate war on wrinkles
Reuters
Fri, 03/22/13 - 10:53 am
JNJ
Botox
Allergan
Mentor
Dysport
Xeomin
4 Key Drug Approvals Expected In The Next 30 Days
investors.com
Sat, 03/16/13 - 10:55 am
Biogen Idec
BG-12
multiple sclerosis
MS
Remodulin
United Therapeutics
lung disease
Invokana
JNJ
diabetes
type 2 diabetes
Levadex
Allergan
migraine
Some Houston physicians paid thousands by big pharma companies
Bizjournals.com
Wed, 03/13/13 - 10:39 am
physician payments
Allergan
FDA approves new silicone breast implant from Allergan
Reuters
Thu, 02/21/13 - 11:56 am
Allergan
FDA
breast implants
Allergan’s Botox Put Boy on Respirator, Lawyer Tells Jury
Bloomberg
Wed, 02/20/13 - 11:49 am
Allergan
Botox
misbranding
off-label
Allergan and MAP: Pharma Buyout With a 60% Premium
Motley Fool
Wed, 02/13/13 - 10:24 am
Allergan
MAP Pharmaceuticals
M&A
Allergan wants to trim obesity treatment unit
The Deal
Sun, 02/10/13 - 11:51 am
Allergan
obesity
weight loss
Lap-Band
Allergan's Healthy Prospects
TheStreet.com
Fri, 02/8/13 - 11:14 am
Allergan
MAP Pharmaceuticals
Allergan Seeks to Sell Lap-Band and Obesity Unit By June
Bloomberg
Tue, 02/5/13 - 06:12 pm
Allergan
Lap-Band
obesity
M&A
Allergan misses in quarter, but 2013 view tops forecasts
Reuters
Tue, 02/5/13 - 10:56 am
earnings
Allergan
Spectrum Pharma's Bladder Cancer Bamboozle
TheStreet.com
Fri, 02/1/13 - 11:32 am
Spectrum Pharmaceuticals
bladder cancer
apaziquone
Allergan
Allergan Fourth Quarter Earnings Sneak Peek
Wall St. Cheat Sheet
Fri, 02/1/13 - 11:30 am
earnings
Allergan
Allergan wins round in patent fight over Lumigan
Reuters
Tue, 01/29/13 - 10:27 am
Allergan
patents
Lumigan
Teva
Sandoz
glaucoma
This Week in Biotech: Part 2
Motley Fool
Sun, 01/27/13 - 11:20 am
Roche
Novartis
Impax Laboratories
MAP Pharmaceuticals
Allergan
Which Biotech Company Will Be Bought Out Next?
Motley Fool
Fri, 01/25/13 - 10:40 am
Vivus
Theravance
Roche
MAP Pharmaceuticals
M&A
Immunogen
GSK
Eli Lilly
Bristol-Myers Squibb
AstraZeneca
Allergan
3 Biotech Stocks Surging Higher With Volume
Seeking Alpha
Fri, 01/25/13 - 08:15 am
Allergan
Keryx
MAP Pharmaceuticals
Threshold Pharmaceuticals
Allergan drops $958M on migraine drug maker MAP Pharma
Mass Device
Wed, 01/23/13 - 09:24 pm
Allergan
M&A
migraine

Pages